Posted on June 8, 2021 by Scott Shuda
TFF Pharmaceuticals, Inc. has emerged as one of the favorite names within the Breakout Investors community. An early-stage biopharmaceutical company, TFFP is focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. The initial focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions.
What the Breakout community likes about TFFP is its “many shots on goal” opportunities. The company is engaged in numerous partnership relationships involving a long list of potential drug applications.
Dan is among the most active commentators, here is post pointing to his current thoughts:
Here is a discussion around a recent Seeking Alpha article on TFFP.
Here is a link to a long discussion following the company’s most recent earnings call.
Disclosure: I am long TFFP and might buy or sell shares at any time.